Bisoprolol Fumarate And Hydrochlorothiazide Tablet
Product Images NDC 10135-742

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 10135-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bisoprolol-fumarate (Bisoprolol Fumarate)

FDA Label Image

5-100ct (Label 100ct 5mg)

FDA Label Image

2.5-100ct (Label 100ct)

FDA Label Image

10-30ct (Label 30ct 10mg)

This is a description of a medication. The medication is called Bisoprolol Fumarate and Hydrochlorothiazide, in tablet form, manufactured for distribution by Martex Pharmaceuticals in New Castle, Delaware, US. The label advises that the medication should be kept out of the reach of children.*

FDA Label Image

10-500ct (Label 500ct 10mg)

This is a description of Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP. Each tablet contains 10 mg Bisoprolol Fumarate and 625 mg Hydrochlorothiazide. The package brochure provides complete instructions for use. Tablets should be stored at a temperature between 20° and 25°C (68°-77°F). These tablets should be kept out of reach of children. They are manufactured for distributed by Martex Pharmaceutical in New Castle, DE.*

FDA Label Image

5-500ct (Label 500ct 5mg)

This is a description of Bisoprolol Fumarate and Hydrochlorothiazide Tablets, which are used for high blood pressure. The tablets contain Bisoprolol fumarate and Hydrochorothiazde in specified amounts. The dosage and usage instructions are given in a package brochure. The tablets should be stored at room temperature and kept away from children. The tablets are manufactured by Martex Pharmaceutcal, New Caste, DE.*

FDA Label Image

2.5-500ct (Label 500ct)

This is a description of a drug with NDC code 10135-0740-05. Each tablet contains Bisoprolol Fumarate 25g and Hydrochlorothiazide 625mg. The drug is manufactured in 500 tablets and is under USP Control. The directions for dosage can be found in an accompanying package brochure.*

FDA Label Image

Thiazide-structure (Thiazide Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.